Published 18 days ago • loading... • Updated 18 days ago

RNA Chemical Tag Emerges as Hidden Driver of Kidney Damage in Diabetes

A new study shows that the RNA demethylase FTO stabilizes EGR1 mRNA through m6A modification, activating a STING1-driven inflammatory cascade that injures podocytes in diabetic kidney disease.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

BIOENGINEER.ORG

RNA Chemical Tag Emerges as Hidden Driver of Kidney Damage in Diabetes

A new study shows that the RNA demethylase FTO stabilizes EGR1 mRNA through m6A modification, activating a STING1-driven inflammatory cascade that injures podocytes in diabetic kidney disease.

18 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated18 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BIOENGINEER.ORG broke the news 18 days ago on Saturday, October 10, 2026.

Sources are mostly out of (0)

RNA Chemical Tag Emerges as Hidden Driver of Kidney Damage in Diabetes

1 Articles

1 Articles

RNA Chemical Tag Emerges as Hidden Driver of Kidney Damage in Diabetes

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Lilly’s ‘Triple-G’ Drug Tops Novo’s Ozempic in Diabetes Trial

Association Asks the Government to Equation Compulsory Licenses for Obesity Drugs

The Shocking Life of a Father Who Waits for Hours Outside His Child's School

GLP-1 users are suffering from these key deficiencies, research reveals

Long Châu, in Partnership with Boehringer Ingelheim, Protects the Cardiovascular and Kidney Health of People with Diabetes.

Mankind Pharma Shares Jump 8% as Q2 Profit Rises 38% to Rs 716 Crore

Similar News Topics

Similar News Topics

More stories like this

Lilly’s ‘Triple-G’ Drug Tops Novo’s Ozempic in Diabetes Trial

Association Asks the Government to Equation Compulsory Licenses for Obesity Drugs

The Shocking Life of a Father Who Waits for Hours Outside His Child's School

GLP-1 users are suffering from these key deficiencies, research reveals

Long Châu, in Partnership with Boehringer Ingelheim, Protects the Cardiovascular and Kidney Health of People with Diabetes.

Mankind Pharma Shares Jump 8% as Q2 Profit Rises 38% to Rs 716 Crore

RNA Chemical Tag Emerges as Hidden Driver of Kidney Damage in Diabetes

1 Articles

1 Articles

RNA Chemical Tag Emerges as Hidden Driver of Kidney Damage in Diabetes

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Lilly’s ‘Triple-G’ Drug Tops Novo’s Ozempic in Diabetes Trial

Association Asks the Government to Equation Compulsory Licenses for Obesity Drugs

The Shocking Life of a Father Who Waits for Hours Outside His Child's School

GLP-1 users are suffering from these key deficiencies, research reveals

Long Châu, in Partnership with Boehringer Ingelheim, Protects the Cardiovascular and Kidney Health of People with Diabetes.

Mankind Pharma Shares Jump 8% as Q2 Profit Rises 38% to Rs 716 Crore

Similar News Topics

Similar News Topics

More stories like this

Lilly’s ‘Triple-G’ Drug Tops Novo’s Ozempic in Diabetes Trial

Association Asks the Government to Equation Compulsory Licenses for Obesity Drugs

The Shocking Life of a Father Who Waits for Hours Outside His Child's School

GLP-1 users are suffering from these key deficiencies, research reveals

Long Châu, in Partnership with Boehringer Ingelheim, Protects the Cardiovascular and Kidney Health of People with Diabetes.

Mankind Pharma Shares Jump 8% as Q2 Profit Rises 38% to Rs 716 Crore

Bias Distribution

Factuality